OSE Immunotherapeutics (XPAR:OSE) Other Stockholders Equity : €-34.59 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Other Stockholders Equity?

OSE Immunotherapeutics's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €-34.59 Mil.

OSE Immunotherapeutics's quarterly Other Stockholders Equity declined from Dec. 2022 (€-18.35 Mil) to Jun. 2023 (€-34.93 Mil) but then increased from Jun. 2023 (€-34.93 Mil) to Dec. 2023 (€-34.59 Mil).

OSE Immunotherapeutics's annual Other Stockholders Equity declined from Dec. 2021 (€-4.41 Mil) to Dec. 2022 (€-18.35 Mil) and declined from Dec. 2022 (€-18.35 Mil) to Dec. 2023 (€-34.59 Mil).

OSE Immunotherapeutics Other Stockholders Equity Historical Data

The historical data trend for OSE Immunotherapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Other Stockholders Equity Chart

OSE Immunotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

11.69

8.87

-4.41

-18.35

-34.59

OSE Immunotherapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															-4.41	-20.09	-18.35	-34.93	-34.59

OSE Immunotherapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

OSE Immunotherapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics (XPAR:OSE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

6OP:Germany

Address

22, Boulevard Benoni Goullin, Nantes, FRA, 44200

Website

http://www.ose-immuno.com

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics (XPAR:OSE) Headlines

No Headlines